Some results have been hidden because they may be inaccessible to you.Show inaccessible results
Nephs: CKD in T2D Treatment | CKD in T2D Amplifies CV Risk
SponsoredView A Cardiorenal Therapy For CKD in T2D That Delays CKD Progression In Patients. Act Now To Reduce Cardiorenal Risk For Your Patients With A Once-Daily Pill.Contact a Representative · Patient Profiles · Safety Information · FDA-Approved Treatment


Feedback